Antibiotic Resistance Market By Disease (Urinary Tract Infections (UTIs), Skin and Soft Tissue Infections (SSTIs), Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Bloodstream Infections, and Others), By Pathogen (Gram-positive Bacteria, Gram-negative Bacteria, Mycobacteria, Anaerobes, and Fungi), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, and Others), By Mechanism of Action (Beta-Lactamase Inhibitors, Protein Synthesis Inhibitors, DNA/RNA Synthesis Inhibitors, Cell Membrane Disruptors, and Others), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Disease

• Urinary Tract Infections (UTIs)
• Skin and Soft Tissue Infections (SSTIs)
• Gastrointestinal Infections
• Sexually Transmitted Infections (STIs)
• Bloodstream Infections
• Others

By Pathogen

• Gram-positive Bacteria
• Gram-negative Bacteria
• Mycobacteria
• Anaerobes
• Fungi

By Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination therapies
• Cephalosporins
• Others

By Mechanism of Action

• Beta-Lactamase Inhibitors
• Protein Synthesis Inhibitors
• DNA/RNA Synthesis Inhibitors
• Cell Membrane Disruptors
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Pfizer Inc.
• Merck & Co., Inc.
• Johnson & Johnson
• Bayer AG
• Novartis International AG
• GlaxoSmithKline (GSK)
• AbbVie Inc.
• Astellas Pharma Inc.
• Sanofi S.A.
• Eli Lilly and Company
• Bristol Myers Squibb
• Roche Holding AG
• Cepheid (Danaher Corporation)
• Theravance Biopharma
• Melinta Therapeutics